Hives Study

Darlinghurst Sydney

Are you suffering from recurrent hives that have no specific cause or trigger, do not respond to antihistamines and last for 6 weeks or longer?

You could have a condition called chronic spontaneous urticaria.

Momentum Clinical Research are testing an investigational treatment that aims to reduce symptoms and make life more comfortable for those who suffer from this condition.

Description

What to expect

Study details

Ages

18+ years of age

Duration

Approximately 1 year with 14 clinic visits. Followed by a 16 week follow up period with 4 clinic visits.

Compensation

Study treatments and procedures will be provided free of charge and participants will be reimbursed for reasonable expenses associated with study.

Eligibility Criteria

You may be eligible to join this study if you:

Are 18 years or over

Have had recurrent hives (urticaria) that lasts for 6 weeks or longer

Are taking a regular dose of antihistamines

Other inclusion and exclusion criteria will apply.

Locations

Darlinghurst Sydney

Description

Chronic spontaneous urticaria (CSU) is a condition that causes sufferers to break out in itchy hives that can last for 6 weeks or longer. Many people with this condition experience recurrent symptoms even when no external allergen or trigger is present, and many do not respond to antihistamine or other available treatments. Living with recurrent hives is uncomfortable and impacts the quality of life of those who have this condition and improved treatment options are needed.

CSU is caused by the inappropriate activation and degranulation of the skins mast cells. Momentum Clinical Research is conducting a study on an investigational treatment that is designed to reduce the activity and numbers of mast cells to treat people with CSU, reduce symptoms and improve quality of life.

What to expect

The investigational treatment will be given via injection and the study will evaluate the effectiveness of different dosages to reduce symptoms.

During the first 24 weeks of the study, participants will be randomly assigned to be given the active study treatment every 4 or 8 weeks, or a placebo every 4 weeks.

During the next 28 weeks, all participants will be assigned to receive the active study treatment every 4 or 8 weeks.

Regular assessments will be conducted to monitor symptoms while on the investigational treatment.

By participating in a clinical trial, you’re helping shape the future of medicine. Your involvement not only benefits you but also contributes to developing groundbreaking treatments for others living with similar conditions. Together, we can improve healthcare for generations to come.

Apply now

Fill out your details, and our team will be in touch to discuss your potential involvement in this study and answer any questions you may have.

*You can unsubscribe or opt out at any time.

We collect personal information, such as your name, address and contact details, and details of your medical conditions, that enables us to identify if you may be eligible to participate in a current or future study. On occasion we may also contact people on our database by email, with general news and information relevant to our studies and volunteers. By submitting this form you agree to receive email and text notifications about this and other enrolling studies. You can unsubscribe or opt out at any time. We do not sell, share or distribute our database under any circumstances.

We will collect this information directly from you. If you consent to release of medical records, we will obtain medical information from other agencies on your behalf if these are required for your participation in any clinical study at Momentum Clinical Research.

Security of your information is important. Personal information collected is stored by third party data storage providers. We believe these providers offer safe and secure systems.

All information we collect about you will be treated with confidentiality and can be accessed only by Momentum Clinical Research employees.

By completing our online enrolment form, or any other forms we send you, you agree to us holding your personal details within our databases.

There is no obligation for you to participate in a study that we contact you about. If you decline to participate in a study, that will not affect your eligibility for participation in another study.

Home
Clinical Trials
Hives Study Sydney DH Ctx

Hives Study

Darlinghurst Sydney

Are you suffering from recurrent hives that have no specific cause or trigger, do not respond to antihistamines and last for 6 weeks or longer?

You could have a condition called chronic spontaneous urticaria.

Momentum Clinical Research are testing an investigational treatment that aims to reduce symptoms and make life more comfortable for those who suffer from this condition.

Description

What to expect

Study details

Ages

18+ years of age

Duration

Approximately 1 year with 14 clinic visits. Followed by a 16 week follow up period with 4 clinic visits.

Compensation

Study treatments and procedures will be provided free of charge and participants will be reimbursed for reasonable expenses associated with study.

Eligibility Criteria

You may be eligible to join this study if you:

Are 18 years or over

Have had recurrent hives (urticaria) that lasts for 6 weeks or longer

Are taking a regular dose of antihistamines

Other inclusion and exclusion criteria will apply.

Locations

Darlinghurst Sydney

Description

What to expect

The investigational treatment will be given via injection and the study will evaluate the effectiveness of different dosages to reduce symptoms.

During the first 24 weeks of the study, participants will be randomly assigned to be given the active study treatment every 4 or 8 weeks, or a placebo every 4 weeks.

During the next 28 weeks, all participants will be assigned to receive the active study treatment every 4 or 8 weeks.

Regular assessments will be conducted to monitor symptoms while on the investigational treatment.

Apply now

Fill out your details, and our team will be in touch to discuss your potential involvement in this study and answer any questions you may have.

*You can unsubscribe or opt out at any time.

We collect personal information, such as your name, address and contact details, and details of your medical conditions, that enables us to identify if you may be eligible to participate in a current or future study. On occasion we may also contact people on our database by email, with general news and information relevant to our studies and volunteers. By submitting this form you agree to receive email and text notifications about this and other enrolling studies. You can unsubscribe or opt out at any time. We do not sell, share or distribute our database under any circumstances.

We will collect this information directly from you. If you consent to release of medical records, we will obtain medical information from other agencies on your behalf if these are required for your participation in any clinical study at Momentum Clinical Research.

Security of your information is important. Personal information collected is stored by third party data storage providers. We believe these providers offer safe and secure systems.

All information we collect about you will be treated with confidentiality and can be accessed only by Momentum Clinical Research employees.

By completing our online enrolment form, or any other forms we send you, you agree to us holding your personal details within our databases.

There is no obligation for you to participate in a study that we contact you about. If you decline to participate in a study, that will not affect your eligibility for participation in another study.